Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date. 
 |
U.S. National Institute for Allergy and Infectious Diseases - February, 2005
To view the PDF flyer, please click here.
See also: NIAID Seeks Applicants to Lead Clinical Trials Units for Revamped HIV/AIDS Networks
Two pre-application meetings will be held in the United States for representatives of institutions that would like to learn more about the Request for Applications (RFA) to establish Clinical Trials Units (CTUs)as part of the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health's Division of AIDS (NIH/DAIDS).
Domestic and international, public or private, for-profit or non-profit entities are eligible to respond to this solicitation, the second of two RFAs that will restructure NIAID's HIV/AIDS Clinical Trials Networks to better conduct and coordinate AIDS research. The first RFA, released inNovember 2004, will establish Leadership for the Clinical Trials Networks.
Potential CTU applicants are invited to attend one of two domestic pre-application meetings offered in March 2005. The first day of each meeting will consist of an NIH grant-writing workshop. The second day will feature an overview of CTU application requirements, procedures and the review process. Applicants may attend one or both days of the meeting. Pre-Registration is strongly suggested prior to each meeting.
3/8 - Pre-application meeting
Masur Auditorium (Building 10)
NIH Campus
3/17 - Grant-writing workshop
3/18 - Pre-application meeting
Both days of the meeting will be held at:
Radisson Hotel Miami
1601 Biscayne Boulevard
Miami, FL 33132
(305) 374-0000
Information on registration, accommodations and meeting logistics(including arrangements for individuals with disabilities) is available at http://www.blsmeetings.net/ctu. Details on the Clinical Trials Networks restructuring and the full text of both RFAs is available at:
http://www.niaid.nih.gov/daids/rfa/network06
050215
NI050204
Published 2005 - National Institute of Allergy and Infectious Diseases . All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .